Amarin adds O’Connor to board of directors. O’Connor brings more than 30 years of experience in government and policy, pharmaceutical industry, banking and finance experience to the Amarin Board. He currently serves as CEO of the Irish Pharmaceutical Healthcare Association and as a Board Member of the Irish Medicines Verification Organisation
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AMRN:
- Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O’Connor to Company’s Board of Directors
- Amarin announces VAZKEPA approved by Israel’s MOH
- Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved by Israel’s Ministry of Health
- Amarin says board ‘ready’ to unlock true potential of VASCEPA/VAZKEPA
- Amarin Announces Board Departures
